ステロイド注射市場：製品タイプ、投与経路、流通チャネル、用途別-2023～2030年の世界予測

ステロイド注射の世界市場は大きく成長し、2023年には38億218万米ドル、CAGR13.47%と予測され、2030年には驚異的な92億5,049万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のステロイド注射市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ステロイド注射の世界市場規模および予測は？

2.予測期間中、世界のステロイド注射市場を形成するCOVID-19の阻害要因と影響は？

3.ステロイド注射の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.ステロイド注射の世界市場における競争戦略は？

5.ステロイド注射の世界市場における技術動向と規制の枠組みは？

6.ステロイド注射の世界市場における主要ベンダーの市場シェアは？

7.ステロイド注射の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 整形外科疾患の発生に伴う高齢者人口の増加
    • 若者の間でのボディビルの人気
  • 抑制要因
    • ステロイド注射の使用に対する厳しい規制
  • 機会
    • 整形手術への関心が高まる
    • ステロイド注射の採用と承認
  • 課題
    • ステロイドの摂取に伴う有害な副作用
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 ステロイド注射市場：製品タイプ別

• イントロダクション
• コルチゾン
• ヒドロコルチゾン
• メチルプレドニゾロン
• トリアムシノロン

第7章 ステロイド注射市場：投与経路別

• イントロダクション
• 硬膜外
• 関節内
• 筋肉内
• 静脈内

第8章 ステロイド注射市場：流通チャネル別

• イントロダクション
• 病院薬局
• 小売薬局
• 専門クリニック

第9章 ステロイド注射市場：用途別

• イントロダクション
• 強直性脊椎炎
• 背中の痛み
• 滑液包炎
• がん
• 痛風
• 変形性関節症
• 乾癬性関節炎
• 関節リウマチ

第10章 南北アメリカのステロイド注射市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のステロイド注射市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのステロイド注射市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. STEROID INJECTIONS MARKET RESEARCH PROCESS
• FIGURE 2. STEROID INJECTIONS MARKET SIZE, 2022 VS 2030
• FIGURE 3. STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
• FIGURE 5. STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2022 VS 2030 (%)
• FIGURE 6. STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 7. STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. STEROID INJECTIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. STEROID INJECTIONS MARKET DYNAMICS
• FIGURE 10. STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 5. STEROID INJECTIONS MARKET SIZE, BY CORTISONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 10. STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. STEROID INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. STEROID INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. STEROID INJECTIONS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 15. STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. STEROID INJECTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. STEROID INJECTIONS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. STEROID INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. STEROID INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. STEROID INJECTIONS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. CANADA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. CHINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. INDIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. ITALY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. POLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. QATAR STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 196. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 197. STEROID INJECTIONS MARKET LICENSE & PRICING

The Global Steroid Injections Market is forecasted to grow significantly, with a projected USD 3,802.18 million in 2023 at a CAGR of 13.47% and expected to reach a staggering USD 9,250.49 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Steroid Injections Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Steroid Injections Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Cortisone, Hydrocortisone, Methylprednisolone, and Triamcinolone. The Cortisone is projected to witness significant market share during forecast period.

Based on Administration Route, market is studied across Epidural, Intra-Articular, Intramuscular, and Intravenous. The Epidural is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacy, Retail Pharmacy, and Specialty Clinics. The Retail Pharmacy is projected to witness significant market share during forecast period.

Based on Application, market is studied across Ankylosing Spondylitis, Back pain, Bursitis, Cancer, Gout, Osteoarthritis, Psoriatic Arthritis, and Rheumatoid Arthritis. The Psoriatic Arthritis is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Steroid Injections Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Steroid Injections Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Steroid Injections Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Steroid Injections Market?

4. What is the competitive strategic window for opportunities in the Global Steroid Injections Market?

5. What are the technology trends and regulatory frameworks in the Global Steroid Injections Market?

6. What is the market share of the leading vendors in the Global Steroid Injections Market?

7. What modes and strategic moves are considered suitable for entering the Global Steroid Injections Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Steroid Injections Market, by Product Type, 2022 vs 2030
• 4.3. Steroid Injections Market, by Administration Route, 2022 vs 2030
• 4.4. Steroid Injections Market, by Distribution Channel, 2022 vs 2030
• 4.5. Steroid Injections Market, by Application, 2022 vs 2030
• 4.6. Steroid Injections Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing geriatric population along with occurrences of orthopedic disorders
    • 5.1.1.2. Popularity of bodybuilding among young people
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulation for steroid injection usage
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing attraction towards plastic surgeries
    • 5.1.3.2. Introduction and approval of the steroid injections
  • 5.1.4. Challenges
    • 5.1.4.1. Harmful side effects associated with the consumption of steroids
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Steroid Injections Market, by Product Type

• 6.1. Introduction
• 6.2. Cortisone
• 6.3. Hydrocortisone
• 6.4. Methylprednisolone
• 6.5. Triamcinolone

7. Steroid Injections Market, by Administration Route

• 7.1. Introduction
• 7.2. Epidural
• 7.3. Intra-Articular
• 7.4. Intramuscular
• 7.5. Intravenous

8. Steroid Injections Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacy
• 8.3. Retail Pharmacy
• 8.4. Specialty Clinics

9. Steroid Injections Market, by Application

• 9.1. Introduction
• 9.2. Ankylosing Spondylitis
• 9.3. Back pain
• 9.4. Bursitis
• 9.5. Cancer
• 9.6. Gout
• 9.7. Osteoarthritis
• 9.8. Psoriatic Arthritis
• 9.9. Rheumatoid Arthritis

10. Americas Steroid Injections Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Steroid Injections Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Steroid Injections Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing